With effect from February 28, 2024, the subscription rights in Enzymatica AB will be traded on First North Growth Market. Trading will continue up until and including March 08, 2024. Instrument: Subscription rights Short name: ENZY TR Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021626702 Order book ID: 325502 Market Segment: First North STO Tick Size: MiFID II tick size table With effect from February 28, 2024, the paid subscription shares in Enzymatica AB will be traded on First North Growth Market. Trading will continue until further notice. Instrument: Paid subscription shares Short name: ENZY BTA Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021626710 Order book ID: 325501 Market Segment: First North STO Tick Size: MiFID II tick size table For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com Nasdaq Stockholm AB
Aktien»Nachrichten»ENZYMATICA AKTIE»Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Enzymatica AB (97/24)
Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Enzymatica AB (97/24)
© 2024 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.07. | Enzymatica AB: Interim report Q2/2024: Enzymatica builds momentum for expansion | LUND, Sweden, July 18, 2024 /PRNewswire/ --
Second quarter
January-June
Net sales reached SEK 6.4 (8.8) million. The operating... ► Artikel lesen | |
| 18.07. | Enzymatica AB: Enzymatica's Board of Directors updates the financial targets | LUND, Sweden, July 18, 2024 /PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) has decided to update the company's financial goals. The background is that the company will likely... ► Artikel lesen | |
| 18.07. | Notice of Extraordinary General Meeting in Enzymatica AB (publ) | LUND, Sweden, July 18, 2024 /PRNewswire/ -- The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the "Company") are hereby invited to attend the Extraordinary General Meeting ("EGM")... ► Artikel lesen | |
| 18.07. | Enzymatica AB: Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, BELARUS, SINGAPORE... ► Artikel lesen | |
| 13.06. | ENZYMATICA AB: Interim results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
